Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65


Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.

Tai WC, Liang CM, Lee CH, Chiu CH, Hu ML, Lu LS, Kuo YH, Kuo CM, Yen YH, Kuo CH, Chiou SS, Wu KL, Chiu YC, Hu TH, Chuah SK.

Biomed Res Int. 2015;2015:623732. doi: 10.1155/2015/623732. Epub 2015 May 19.


Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal Gynostemma saponins.

Chen L, Tai WC, Brar MS, Leung FC, Hsiao WL.

PLoS One. 2015 May 20;10(5):e0126807. doi: 10.1371/journal.pone.0126807. eCollection 2015.


Proteomic analysis of secreted proteins by human bronchial epithelial cells in response to cadmium toxicity.

Chen DJ, Xu YM, Zheng W, Huang DY, Wong WY, Tai WC, Cho YY, Lau AT.

Proteomics. 2015 May 6. doi: 10.1002/pmic.201400489. [Epub ahead of print]


URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.

Xing S, Zhang B, Hua R, Tai WC, Zeng Z, Xie B, Huang C, Xue J, Xiong S, Yang J, Liu S, Li H.

BMC Cancer. 2015 May 7;15:368. doi: 10.1186/s12885-015-1378-7.


Predictive factors for inadequate colon preparation before colonoscopy.

Cheng RW, Chiu YC, Wu KL, Rayner CK, Tai WC, Hu ML, Chou YP, Chuah SK, Liang CM, Lu LS.

Tech Coloproctol. 2015 Feb;19(2):111-5. doi: 10.1007/s10151-014-1259-0. Epub 2015 Jan 6.


Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis.

Hsu PI, Lu CL, Wu DC, Kuo CH, Kao SS, Chang CC, Tai WC, Lai KH, Chen WC, Wang HM, Cheng JS, Tsai TJ, Chuah SK.

Clin Gastroenterol Hepatol. 2015 May;13(5):859-66.e1. doi: 10.1016/j.cgh.2014.09.033. Epub 2014 Sep 20.


Quinolone-containing therapies in the eradication of Helicobacter pylori.

Chuah SK, Tai WC, Lee CH, Liang CM, Hu TH.

Biomed Res Int. 2014;2014:151543. doi: 10.1155/2014/151543. Epub 2014 Aug 28.


Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice.

Liang CM, Cheng JW, Kuo CM, Chang KC, Wu KL, Tai WC, Chiu KW, Chiou SS, Lin MT, Hu TH, Chuah SK.

Biomed J. 2014 Sep-Oct;37(5):326-30. doi: 10.4103/2319-4170.125650.


Decreased gastric motility in type II diabetic patients.

Chiu YC, Kuo MC, Rayner CK, Chen JF, Wu KL, Chou YP, Tai WC, Hu ML.

Biomed Res Int. 2014;2014:894087. doi: 10.1155/2014/894087. Epub 2014 Jul 23.


The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication.

Tai WC, Lee CH, Chiou SS, Kuo CM, Kuo CH, Liang CM, Lu LS, Chiu CH, Wu KL, Chiu YC, Hu TH, Chuah SK.

PLoS One. 2014 Aug 20;9(8):e105822. doi: 10.1371/journal.pone.0105822. eCollection 2014.


Outcome of holiday and nonholiday admission patients with acute peptic ulcer bleeding: a real-world report from southern Taiwan.

Wu TC, Chuah SK, Chang KC, Wu CK, Kuo CH, Wu KL, Chiu YC, Hu TH, Tai WC.

Biomed Res Int. 2014;2014:906531. doi: 10.1155/2014/906531. Epub 2014 Jul 1.


The influential roles of antibiotics prophylaxis in cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments.

Yang SC, Chen JC, Tai WC, Wu CK, Lee CH, Wu KL, Chiu YC, Wang JH, Lu SN, Chuah SK.

PLoS One. 2014 May 2;9(5):e96394. doi: 10.1371/journal.pone.0096394. eCollection 2014.


Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor.

Law CK, Kwok HH, Poon PY, Lau CC, Jiang ZH, Tai WC, Hsiao WW, Mak NK, Yue PY, Wong RN.

Chin Med. 2014 Apr 2;9(1):11. doi: 10.1186/1749-8546-9-11.


The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy.

Kuo YH, Lu SN, Chen CH, Chang KC, Hung CH, Tai WC, Tsai MC, Tseng PL, Hu TH, Wang JH.

PLoS One. 2014 Mar 28;9(3):e93160. doi: 10.1371/journal.pone.0093160. eCollection 2014.


Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.

Wang JH, Chuah SK, Lu SN, Hung CH, Kuo CM, Tai WC, Chiou SS.

Liver Int. 2014 Oct;34(9):1340-8. doi: 10.1111/liv.12525. Epub 2014 Mar 28.


Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan.

Tai WC, Chiu CH, Liang CM, Chang KC, Kuo CM, Chiu YC, Wu KL, Hu ML, Chou YP, Chiou SS, Chiu KW, Kuo CH, Hu TH, Lin MT, Chuah SK.

Gastroenterol Res Pract. 2013;2013:932478. doi: 10.1155/2013/932478. Epub 2013 Oct 22.


Current status in the treatment options for esophageal achalasia.

Chuah SK, Chiu CH, Tai WC, Lee JH, Lu HI, Changchien CS, Tseng PH, Wu KL.

World J Gastroenterol. 2013 Sep 7;19(33):5421-9. doi: 10.3748/wjg.v19.i33.5421. Review.


The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett's Esophagus in Taiwan.

Kao SS, Chen WC, Hsu PI, Chuah SK, Lu CL, Lai KH, Tsai FW, Chang CC, Tai WC.

Gastroenterol Res Pract. 2013;2013:480325. doi: 10.1155/2013/480325. Epub 2013 Aug 12.


The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria.

Chiu YC, Tai WC, Chuah SK, Hsu PI, Wu DC, Wu KL, Huang CC, Ho JC, Ring J, Chen WC.

Gastroenterol Res Pract. 2013;2013:436727. doi: 10.1155/2013/436727. Epub 2013 Jul 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk